KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Free Cash Flow (2016 - 2025)

Petmed Express' Free Cash Flow history spans 16 years, with the latest figure at -$9.2 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 372.67% year-over-year to -$9.2 million; the TTM value through Dec 2025 reached -$20.0 million, down 1048.62%, while the annual FY2025 figure was $2.5 million, 40.98% down from the prior year.
  • Free Cash Flow reached -$9.2 million in Q4 2025 per PETS's latest filing, down from -$4.8 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $17.9 million in Q1 2021 to a low of -$13.6 million in Q2 2025.
  • Average Free Cash Flow over 5 years is $2.1 million, with a median of $273000.0 recorded in 2021.
  • Peak YoY movement for Free Cash Flow: surged 700.44% in 2022, then plummeted 1456.68% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at $8.4 million in 2021, then surged by 42.39% to $12.0 million in 2022, then crashed by 103.81% to -$456000.0 in 2023, then tumbled by 326.1% to -$1.9 million in 2024, then plummeted by 372.67% to -$9.2 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's Free Cash Flow are -$9.2 million (Q4 2025), -$4.8 million (Q3 2025), and -$13.6 million (Q2 2025).